THE RELATIONSHIP BETWEEN COGNITIVE IMPAIRMENT AND THE LEVEL OF BDNF IN YOUNG PEOPLE
Main Article Content
Abstract
The relevance of the study is due to interest in the problem of cognitive deficits, actively developed in the modern scientific literature. At the same time, the mechanisms of the development of cognitive deficiency remain insufficiently studied.
The aim of the study is to study the quantitative content of the cerebral neurotrophic factor of human blood serum (BDNF) and its effect on cognitive function in young people.
The material of the study was the results of psychological testing of two groups of persons (19-27 years and 41-60 years), data on the level of BDNF in the sera of the interviewed. We used: questionnaire «quality of life – neurological module», BDI scale, AR technique. Luria «10 words», the «Schulte table» technique, a technique for studying visual-spatial gnosis. To determine the level of BDNF, the ELISA method was used.
As a result of the study, the average BDNF level was exceeded by more than 20 % in young people compared with representatives of the middle-aged group. In young people, the decline in cognitive functions correlates with an increase in the level of BDNF, which, on the one hand, can be explained both by higher regenerative abilities of the young organism and as a prerequisite for explaining the pathogenetic aspects of the initial manifestations of cognitive deficits.Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Gusev EI, Bogolepova AN. Cognitive disorders in cerebrovascular diseases. M.: MEDpress-inform, 2013. 160 p. Russian (Гусев Е.И., Боголепова А.Н. Когнитивные нарушения при цереброваскулярных заболеваниях. М.: МЕДпресс-информ, 2013. 160 с.)
Topchij NV, Movshich BL, Denisova NV. Opportunities of a general practitioner in the prevention and treatment of cerebrovascular disorders. Russian Medical Journal. 2006; 14(29): 2065-2074. Russian (Топчий Н.В., Мовшич Б.Л., Денисова Н.В. Возможности врача общей практики в профилактике и лечении цереброваскулярных расстройств. Русский медицинский журнал. 2006. Т. 14, № 29. С. 2065-2074)
Starchina JuA, Parfenov VA. Cognitive disorders in cerebrovascular diseases: diagnosis and treatment. Russian Medical Journal. Neurology. 2008; 16(12): 1-3. Russian (Старчина Ю.А., Парфенов В.А. Когнитивные расстройства при цереброваскулярных заболеваниях: диагноз и лечение //РМЖ. Неврология. 2008. Т. 16, № 12. С. 1-3)
Toole JF. Cerebrovascular Disorders. 6 edition. Moscow: GEOTAR-Media Publ., 2007. 590 p. Russian (Тул Дж. Ф. Сосудистые заболевания головного мозга: руководство для врачей. 6-е изд. М.: ГЭОТАР-Медиа, 2007. 590 с.)
Jahno NN, Zaharov VV, Loshkina AB, Koberskaja NN, Mhitarjan JeA. Dementia: a guide for doctors. Moscow: MEDpress-inform, 2010. 272 p. Russian (Яхно Н.Н., Захаров В.В., Лошкина А.Б., Коберская Н.Н., Мхитарян Э.А. Деменции: руководство для врачей. М.: МЕД-пресс-информ, 2010. 272 с.)
Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P. et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989; 34(1): 149-152
Castren E, Võikar V, Rantamäki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2007; 7(1): 18-21
Kuipers SD, Dramham CR. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel. 2006; 9(5): 580-586
Martinowich K, Manjj H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007; 10(9): 1089-1093
Pearse AG. The common peptides and the cytochemistry of their cells of origin. Basic Appl Histochem. 1989; 24(2): 63-73